Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -31.69 | -17.52 |
PEG Ratio (TTM) | -0.01 | -5.47 |
P/S Ratio (TTM) | 8.86 | 34.08 |
P/B Ratio (TTM) | 1.74 | 5.74 |
P/FCF Ratio (TTM) | 295.83 | -147.41 |
Price to 5YR AVG Earnings Ratio | N/A | -33.76 |
Price to 5YR AVG FCF Ratio | N/A | -1.32 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.47% | 286.95% |
ROE (TTM) | -10.98% | -4,206.17% |
Net Profit Margin (TTM) | -27.97% | -1,030.69% |
ROIC 5YR AVG | N/A | -16.05% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 873.25% | N/A | N/A |
Revenue | 506.35% | N/A | N/A |
Net Income | -149.70% | N/A | N/A |
Cash Flow | -19.19% | N/A | N/A |
Health (25%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.05 | 4.93 |
Quick Ratio (TTM) | 4.05 | 4.90 |
D/E Ratio (TTM) | N/A | 1.26 |
Interest Coverage (TTM) | -4.53 | -11.12 |
Piotroski F-Score | 2 | 3 |
Altman Z-Score | N/A | 20.88 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 887.54% |